Skip to content
Screener

Guardant Health GH Business Segments — Sales and marketing expense

Similar metrics at other companies

Grindr logo
GRNDReportable Segment — Sales and marketing expense
$4.08M+115%
Mueller Industries logo
MLIClimate — Sales and marketing expense
$4.08M+11.3%
Hilton Grand Vacations logo
HGVSales of VOIs — Sales and marketing expense
$79M+132%
Mueller Industries logo
MLIIndustrial Metals — Sales and marketing expense
$1.98M+47.8%
Mueller Industries logo
MLIPiping Systems — Sales and marketing expense
$8.41M+4.4%
Tyler Technologies logo
TYLEnterprise Software — Sales and marketing expense
$27.05M+8.3%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$21.9B+294%
Enterprise value$22.5B+265%
P/S20.3×+13.6×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept gh:SellingAndMarketingExpenseAdjusted.

The source filing: Guardant Health’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 5:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001576280-26-000026
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue$301,665$203,471
Less:
Cost of revenue (1)101,56072,185
Research and development expense (1)76,58974,897
Sales and marketing expense (1)154,43094,127
General and administrative expense (1)37,03730,559
Other segment items (2)44,12426,862
Net loss$(112,075)$(95,159)

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Guardant Health's business segments — sales and marketing expense?
Guardant Health (GH) reported business segments — sales and marketing expense of $154.43M in Q1 2026.
How has Guardant Health's business segments — sales and marketing expense changed year-over-year?
Guardant Health's business segments — sales and marketing expense increased by 64.1% year-over-year, from $94.13M to $154.43M.
What is the long-term trend for Guardant Health's business segments — sales and marketing expense?
Over 3 years (2022 to 2025), Guardant Health's business segments — sales and marketing expense has grown at a 17.9% compound annual growth rate (CAGR), from $273.96M to $448.42M.
What does business segments — sales and marketing expense mean?
This represents the costs associated with promoting, selling, and distributing the company's diagnostic tests to healthcare providers and clinical institutions. It includes sales force compensation, advertising, and educational programs to drive test adoption.

Ask your AI about Guardant Health's business segments — sales and marketing expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude